Subscribe free

HPB & Spleen ·

New model predicts poor outcomes in liver surgery for HCC

Surgeons now have a validated model to identify patients at high risk for early non-curative recurrence after liver resection for hepatocellular carcinoma (HCC), crucial for tailoring postoperative care.

  • Early non-curative recurrence significantly increases overall survival risk (hazard ratio 5.39).
  • Median survival drops from 178.6 months to just 34.7 months in early recurrence cases (p < 0.001).

Implementing this model can refine patient monitoring and improve long-term outcomes after HCC surgery.

  • Key predictive factors include elevated alpha-fetoprotein, larger tumor size, multiple tumors, portal invasion, and serosal invasion.

Journal Article by Shibamoto J, Moriguchi M (…) Sugiura T et 8 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →